Process View
A mitotic cell cycle checkpoint that detects and negatively regulates progression through the G1/S transition of the cell cycle in response to DNA damage.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mitotic g1 dna damage checkpoint"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 1.000 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.991 | Human | |
| RB1 | retinoblastoma 1 | 0.973 | ||
| TP53 | tumor protein p53 | 0.969 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.920 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.887 | ||
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.862 | ||
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 0.861 | Human | |
| CDK6 | cyclin-dependent kinase 6 | 0.748 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.706 | ||
| CCND1 | cyclin D1 | 0.690 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.596 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.514 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.484 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.470 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.405 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.375 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.363 | ||
| BRCA1 | breast cancer 1, early onset | 0.350 | ||
| RPA1 | replication protein A1, 70kDa | 0.334 | ||
| CCND3 | cyclin D3 | 0.331 | Human | |
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.324 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.306 | ||
| DAXX | death-domain associated protein | 0.273 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.246 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.226 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.219 | ||
| IER3 | immediate early response 3 | 0.208 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.199 | ||
| PAX3 | paired box 3 | 0.179 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.141 | ||
| CCNE1 | cyclin E1 | 0.139 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.130 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.127 | ||
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.125 | ||
| UBR3 | ubiquitin protein ligase E3 component n-recognin 3 (putative) | 0.119 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.115 | Human | |
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.115 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.109 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.099 | ||
| FADD | Fas (TNFRSF6)-associated via death domain | 0.094 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.094 | Human | |
| RBL2 | retinoblastoma-like 2 (p130) | 0.078 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.071 | Human | |
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.071 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.065 | ||
| RBL1 | retinoblastoma-like 1 (p107) | 0.065 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.064 | ||
| RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.053 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.053 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.050 | ||
| WWOX | WW domain containing oxidoreductase | 0.048 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.045 | ||
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.041 | ||
| ARRB2 | arrestin, beta 2 | 0.039 | ||
| USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.038 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.037 | ||
| RAD18 | RAD18 homolog (S. cerevisiae) | 0.036 | ||
| KRT5 | keratin 5 | 0.030 | ||
| WHSC1 | Wolf-Hirschhorn syndrome candidate 1 | 0.026 | ||
| SUPT16H | suppressor of Ty 16 homolog (S. cerevisiae) | 0.026 | ||
| CCND2 | cyclin D2 | 0.025 | Human | |
| SIAH1 | seven in absentia homolog 1 (Drosophila) | 0.024 | ||
| MARCKSL1 | MARCKS-like 1 | 0.024 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.024 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.023 | ||
| SATB2 | SATB homeobox 2 | 0.022 | ||
| NBN | nibrin | 0.022 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.020 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.020 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.019 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.019 | ||
| SMAD7 | SMAD family member 7 | 0.019 | ||
| BRCA2 | breast cancer 2, early onset | 0.018 | ||
| ATM | ataxia telangiectasia mutated | 0.017 | ||
| MKRN1 | makorin ring finger protein 1 | 0.017 | ||
| RPA2 | replication protein A2, 32kDa | 0.016 | ||
| PCGF2 | polycomb group ring finger 2 | 0.016 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.016 | ||
| NOTCH1 | notch 1 | 0.015 | ||
| POLH | polymerase (DNA directed), eta | 0.014 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.014 | Human | |
| MED1 | mediator complex subunit 1 | 0.014 | ||
| PCNA | proliferating cell nuclear antigen | 0.013 | ||
| E2F3 | E2F transcription factor 3 | 0.013 | ||
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.013 | ||
| ANXA4 | annexin A4 | 0.013 | ||
| TTI1 | Tel2 interacting protein 1 homolog (S. pombe) | 0.013 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.012 | ||
| NMI | N-myc (and STAT) interactor | 0.012 | ||
| GORAB | golgin, RAB6-interacting | 0.012 | ||
| NUCB2 | nucleobindin 2 | 0.011 | ||
| RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | 0.011 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.011 | Human | |
| YY1 | YY1 transcription factor | 0.011 | ||
| CCNA1 | cyclin A1 | 0.011 | ||
| DZIP1 | DAZ interacting protein 1 | 0.011 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.010 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.010 | ||
| YAP1 | Yes-associated protein 1 | 0.010 | ||
| UNG | uracil-DNA glycosylase | 0.010 | ||
| PARP1 | poly (ADP-ribose) polymerase 1 | 0.010 |